Results 1 to 10 of about 321,793 (195)

Can high-frequency transthoracic sonography play a competitive role with high-resolution computed tomography in the assessment of dyspnea?

Egyptian Journal of Chest Disease and Tuberculosis, 2022
Background Transthoracic ultrasound (TUS) can potentially give important complementary information in particular conditions like bedside rapid diagnostic evaluation of dyspneic patients who commonly present to emergency (ER) units.
Gamal Agmy, Mariam H Adeeb, Mohamed Adam, Manal A Mahmoud   +3 more
doaj   +1 more source

Sarcoidosis Presenting as Acute Respiratory Distress Syndrome. [PDF]

, 2018
Sarcoidosis is a multisystem granulomatous disease of unknown origin. It typically involves the lungs and mediastinal lymph nodes in a chronic fashion. However, acute syndrome has been reported possibly in response to systemic release of proinflammatory ...
Chan, Vincent, Lashari, Bilal, Raza, Ahmad, Ward, William   +3 more
core   +2 more sources

Prevalence of dyspnea and its associated factors in patients with chronic obstructive pulmonary disease

Indian Journal of Respiratory Care, 2019
Background: Dyspnea is highly distressing experience of breathlessness that limits the activities of daily living and affects an increasingly large group of patients with respiratory diseases such as chronic obstructive pulmonary disease (COPD).
Sita Sharma, Pramod Sharma
doaj   +1 more source

Early Multi-organ Point-of-Care Ultrasound Evaluation of Respiratory Distress During SARS-CoV-2 Outbreak: Case Report [PDF]

, 2020
Introduction: Coronavirus disease 2019 (COVID-19) is caused by the virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Several case series from Italy and China have highlighted the lung ultrasound findings of this disease ...
Becherer-Bailey, Graham, Farrow II, Robert, Mantuani, Daniel, Nagdev, Arun   +3 more
core  

N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study [PDF]

, 2018
Background Contemporary reconsideration of diagnostic N-terminal pro–B-type natriuretic peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed.
Chen-Tournoux, Annabel A., Christenson, Robert H., Doros, Gheorghe, Gaggin, Hanna K., Hollander, Judd E., Januzzi, James L., Levy, Phillip D., Nagurney, John T., Nowak, Richard M., Pang, Peter S., Patel, Darshita, Peacock, W. Franklin, Rivers, E. Joy, Walters, Elizabeth L.   +13 more
core   +1 more source

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. [PDF]

, 2013
BACKGROUND: Riociguat, a member of a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension. METHODS: In this phase 3,
CHEST-1 Study Group,, D'Armini, AM, Fritsch, A, Ghofrani, HA, Grimminger, F, Hoeper, MM, Jansa, P, Kim, NH, Mayer, E, Neuser, D, Simonneau, G, Wang, C, Weimann, G, Wilkins, MR   +13 more
core   +1 more source

Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? [PDF]

, 2018
Aims: Changes in systolic blood pressure (SBP) during an admission for acute heart failure (AHF), especially those leading to hypotension, have been suggested to increase the risk for adverse outcomes.
Bourge, Robert C., Cleland, John G.F., Cotter, Gad, Davison, Beth A., Edwards, Christopher, Jondeau, Guillaume, Kobrin, Isaac, McMurray, John J.V., Metra, Marco, Milo, Olga, O'Connor, Christopher M., Parker, John D., Rainisio, Maurizio, Senger, Stefanie, Teerlink, John R., Torre-Amione, Guillermo, van Veldhuisen, Dirk J.   +16 more
core   +3 more sources

Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background A proposed cause of dyspnea induced by ticagrelor is an increase in adenosine blood levels. Because caffeine is an adenosine antagonist, it can potentially improve drug tolerability with regard to dyspnea.
Remo H. M. Furtado, Ramkumar V. Venkateswaran, Jose C. Nicolau, Yared Gurmu, Deepak L. Bhatt, Robert F. Storey, P. Gabriel Steg, Giuglia Magnani, Shinya Goto, Mikael Dellborg, Gabriel Kamensky, Daniel Isaza, Philip Aylward, Per Johanson, Marc P. Bonaca   +14 more
doaj   +1 more source

Sex-differences in the multidimensional evaluation of dyspnea in respiratory outpatients

Frontiers in Medicine
BackgroundFemales experience greater dyspnea intensity compared to males. The role of sex in dyspnea quality and emotional responses in respiratory outpatients is unknown.
Kathryn M. Milne, Kathryn M. Milne, Kathryn M. Milne, Julia Zhang, Owen D. Harris, Jordan A. Guenette, Jordan A. Guenette, Jordan A. Guenette   +7 more
doaj   +1 more source

Palliative management of refractory dyspnea in COPD [PDF]

, 2006
Auckland, New ...
Currow, David Christopher, Abernethy, Amy Pickar, Uronis, H E   +2 more
core